The Venture Codex Logo

The Venture Codex

Overview

Pharmaceutical product development for airways-related diseases.

Founded

1997

Deals · 12mo

0

Stage focus

—

Geographic focus

United States

Sector focus

Health Care
Pharmaceutical
Wellness

Investment portfolio

1rounds
NAMEDATESIZE
EnBiotix
Dec 2021Led
$11 MOther Equity
EnBiotix
Dec 2021Led
$11 MOther Equity
1
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Vectura Group: 1 funding rounds are recorded in the selected participation categories.All available history.
Vectura Group: 1 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Other Equity10

Monthly Deal Activity

Vectura Group: 1 deals are recorded across 59 months.All available history.
Vectura Group: 1 deals are recorded across 59 months. All available history
MonthDeals
Dec '211
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Vectura Group: Health & Life Sciences is the largest displayed sector by deal count (1 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Vectura Group: Health & Life Sciences is the largest displayed sector by deal count (1 deals). All available history
SectorDeals
Health & Life Sciences1

Deal Size Distribution

Vectura Group: 1 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Vectura Group: 1 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Vectura Group: United States has the largest recorded deal count among the displayed regions (1 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Vectura Group: United States has the largest recorded deal count among the displayed regions (1 deals). All available history
RegionDeals
United States1
Vectura Group: 2 co-investors are shown, with Cystic Fibrosis Foundation sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Vectura Group: 2 co-investors are shown, with Cystic Fibrosis Foundation sharing 1 recorded deals. All available history
Co-investorShared deals
Cystic Fibrosis Foundation1
Sanford Biosciences1

Investment Strategy

Vectura Group: Led accounts for 100% and participating for 0% of round participation.All available history.
Vectura Group: Led accounts for 100% and participating for 0% of round participation. All available history
CategoryDeals (count)Share (%)
Led1100%
Participating00%
Vectura Group: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Vectura Group: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

Joanne Hombal

Human Resources Director

Karl Keegan

Chief Corporate Development Officer

Sharon Johnson

EVP Delivery Management